Salim Yusuf Selected Research

Hypotension (Low Blood Pressure)

1/2023	Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial.
10/2022	Pharmacogenomic study of heart failure and candesartan response from the CHARM programme.
1/2022	Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.
1/2022	Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
1/2020	One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery.
12/2014	Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial.
4/2014	Clonidine in patients undergoing noncardiac surgery.
2/2013	Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
3/2011	Irbesartan in patients with atrial fibrillation.
12/2008	Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salim Yusuf Research Topics

Disease

193	Stroke (Strokes) 04/2024 - 01/2002
130	Heart Failure 01/2024 - 01/2002
121	Myocardial Infarction 01/2024 - 01/2002
120	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2002
119	Hemorrhage 04/2024 - 02/2003
101	Atrial Fibrillation 12/2022 - 07/2002
50	Hypertension (High Blood Pressure) 05/2024 - 01/2002
39	Acute Coronary Syndrome 11/2019 - 09/2002
36	Vascular Diseases (Vascular Disease) 03/2024 - 03/2002
33	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2002
32	Embolism (Embolus) 04/2021 - 09/2009
30	Peripheral Arterial Disease 05/2024 - 07/2007
29	Ischemic Stroke 10/2023 - 09/2008
23	Thrombosis (Thrombus) 12/2022 - 02/2003
22	Diabetes Mellitus 01/2023 - 03/2002
21	Unstable Angina 01/2018 - 09/2002
19	Type 2 Diabetes Mellitus (MODY) 12/2023 - 11/2003
19	Atherosclerosis 01/2022 - 01/2002
19	ST Elevation Myocardial Infarction 01/2018 - 01/2005
16	Left Ventricular Dysfunction 03/2014 - 01/2002
15	Ischemia 01/2023 - 12/2004
15	Hypotension (Low Blood Pressure) 01/2023 - 09/2003
13	Abdominal Obesity 01/2022 - 01/2003
12	Coronary Disease (Coronary Heart Disease) 01/2023 - 09/2003
11	Cognitive Dysfunction 06/2022 - 10/2008
11	Neoplasms (Cancer) 01/2022 - 10/2004
11	Albuminuria 07/2016 - 03/2003
11	Glucose Intolerance 07/2014 - 02/2003
10	Insulin Resistance 10/2023 - 01/2002
10	Chronic Renal Insufficiency 02/2023 - 04/2007
10	Obesity 01/2022 - 04/2007
9	Hyperkalemia 12/2014 - 01/2002
8	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2004
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 09/2008
7	COVID-19 01/2023 - 11/2020
7	Infections 02/2022 - 05/2014
7	Renal Insufficiency (Renal Failure) 01/2020 - 01/2002
6	Infarction (Infarctions) 10/2020 - 11/2005
5	Hemorrhagic Stroke 01/2022 - 09/2009

Drug/Important Bio-Agent (IBA)

98	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 04/2002
63	candesartanIBA 10/2022 - 09/2003
56	Ramipril (Altace)FDA LinkGeneric 01/2021 - 01/2002
53	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2002
45	Telmisartan (Micardis)FDA Link 01/2021 - 01/2002
44	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 09/2009
42	RivaroxabanIBA 05/2024 - 01/2017
42	Dabigatran FDA Link 01/2020 - 09/2009
36	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2003
36	Clopidogrel (Plavix)FDA Link 11/2021 - 09/2002
31	AnticoagulantsIBA 10/2023 - 02/2003
30	Angiotensin Receptor AntagonistsIBA 01/2023 - 10/2004
29	CreatinineIBA 01/2022 - 01/2002
28	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2005
28	LipidsIBA 10/2022 - 09/2004
23	SodiumIBA 05/2024 - 11/2011
23	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019 - 01/2002
22	Vitamin K FDA Link 01/2022 - 05/2009
20	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2009
17	Fondaparinux (Arixtra)FDA Link 05/2014 - 03/2005
16	omega-Chloroacetophenone (Mace)IBA 03/2024 - 05/2014
16	apixabanIBA 04/2021 - 03/2010
16	Insulin (Novolin)FDA Link 01/2019 - 12/2004
14	PotassiumIBA 05/2024 - 12/2004
14	CholesterolIBA 11/2022 - 07/2007
13	ApolipoproteinsIBA 05/2022 - 09/2004
12	Irbesartan FDA LinkGeneric 01/2020 - 11/2007
11	Insulin Glargine (Lantus)FDA Link 01/2019 - 01/2008
11	Heparin (Liquaemin)FDA LinkGeneric 05/2014 - 02/2003
10	Apolipoproteins B (ApoB)IBA 01/2023 - 09/2004
10	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 09/2011
10	Rosuvastatin Calcium (Crestor)FDA Link 01/2022 - 01/2015
9	HDL CholesterolIBA 10/2022 - 07/2003
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 09/2005
9	Enalapril FDA LinkGeneric 03/2014 - 12/2002
8	Triglycerides (Triacylglycerol)IBA 01/2024 - 07/2003
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
8	Lipoproteins (Lipoprotein)IBA 05/2022 - 07/2008
8	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 07/2006
8	Troponin T (Troponin T1)IBA 01/2022 - 01/2011
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 05/2016
8	Enoxaparin (Lovenox)FDA LinkGeneric 05/2011 - 12/2005
7	LDL CholesterolIBA 01/2024 - 05/2016
7	ORALIT (ORS)IBA 01/2023 - 11/2005
7	Factor Xa InhibitorsIBA 01/2022 - 03/2005
6	AlbuminsIBA 01/2021 - 12/2006
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 12/2002
6	HomocysteineIBA 02/2012 - 01/2002
5	LDL Lipoproteins (beta Lipoproteins)IBA 10/2023 - 04/2015
5	Dietary SodiumIBA 04/2023 - 06/2015
5	C-Reactive ProteinIBA 01/2022 - 07/2006

Therapy/Procedure

144	Therapeutics 11/2023 - 01/2002
28	Percutaneous Coronary Intervention 01/2020 - 02/2003
20	Secondary Prevention 11/2020 - 03/2002
12	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2022 - 11/2003
10	Surgical Amputation (Amputations) 03/2024 - 11/2013
7	Long-Term Care 10/2019 - 04/2012
7	Stents 01/2018 - 09/2010
6	Length of Stay 01/2020 - 07/2002
6	Thrombectomy 01/2018 - 03/2014
6	Drug Therapy (Chemotherapy) 01/2018 - 02/2010